Steatohepatitis Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Steatohepatitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Heart FailureCoronary Artery DiseaseOral Microbiota+9 more
Danderyd Hospital1,400 enrolled1 locationNCT07476703
Recruiting

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

Liver CancerNon-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis+4 more
Institut National de la Santé Et de la Recherche Médicale, France800 enrolled1 locationNCT04690972
Recruiting

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

FibrosisNonalcoholic SteatohepatitisNonalcoholic Fatty Liver Disease+1 more
Peking Union Medical College Hospital200 enrolled1 locationNCT05330923
Recruiting

The Development of MASLD Among Survivors of Breast or Colorectal Cancer

Breast Cancer SurvivorsColorectal (Colon or Rectal) Cancer SurvivorsMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
University of Bern200 enrolled1 locationNCT07280143
Recruiting
Phase 3

Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis

Steatohepatitis, Nonalcoholic
National Taiwan University Hospital210 enrolled1 locationNCT07265297
Recruiting
Not Applicable

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Insulin Sensitivity/ResistanceObesityInsulin Resistance+16 more
Pichamol Jirapinyo, MD, MPH132 enrolled2 locationsNCT06138821
Recruiting

Blood Collection Biorepository for Liver Disease Research

CirrhosisFibrosisHepatitis B+5 more
State University of New York at Buffalo1,000 enrolled1 locationNCT03025074
Recruiting
Not Applicable

To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients

Obesity and OverweightLiver Cancer, AdultMASH - Metabolic Dysfunction-Associated Steatohepatitis
University of California, San Diego50 enrolled1 locationNCT06824974
Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Lung CancerCancer RiskCancer Predisposition Syndrome+28 more
Dana-Farber Cancer Institute5,000 enrolled1 locationNCT05463796
Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Acute Lung Injury(ALI)Liver Cirrhosis+4 more
Beijing Tsinghua Chang Gung Hospital4,000 enrolled1 locationNCT07070362
Recruiting
Phase 2

Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

Metabolic Dysfunction-Associated SteatohepatitisChronic Kidney Disease Stage 3Chronic Kidney Disease Stage 2
Enyo Pharma60 enrolled1 locationNCT06939816
Recruiting
Phase 2

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Steatohepatitis
University of Florida166 enrolled1 locationNCT04501406
Recruiting

CHronic Hepatopathies Associated with ALcohol Consumption and MetAbolic Syndrome

Hepatocellular CarcinomaNon-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis+2 more
Institut National de la Santé Et de la Recherche Médicale, France710 enrolled1 locationNCT05623150
Recruiting

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Hepatocellular CarcinomaLiver TransplantMetabolic Dysfunction-Associated Steatotic Liver Disease+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna1,000 enrolled1 locationNCT06813508
Recruiting
Not Applicable

Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance

ObesityInsulin ResistanceDiabetes Mellitus, Type 2+4 more
Stanford University110 enrolled1 locationNCT05165706
Recruiting

The European NAFLD Registry

Hepatocellular CarcinomaObesityCardiovascular Diseases+9 more
Newcastle University10,000 enrolled37 locationsNCT04442334
Recruiting

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisNon-alcoholic Fatty Liver
Cambridge University Hospitals NHS Foundation Trust2,000 enrolled3 locationsNCT04190849
Recruiting

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

Liver CancerObesityMetabolic Syndrome+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5,000 enrolled1 locationNCT04371042